CV DEATH HAS A NEW OPPONENT
Empagliflozin (JARDIANCE®) is proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease
Empagliflozin (JARDIANCE®) is proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease
 
 

Metabolism_Jardiance_EMPEROR-Preserved FAQ expert snippets - Carolyn Lam_video_15-7-22

Document ID: PC-PH-103969

08/08/2022

Author: Boehringer Ingelheim

Current Time 0:00
Duration 13:08
Loaded: 0.00%
Stream Type LIVE
Remaining Time 13:08
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Related content

     
    PC-PH-103969
    Production date: Aug 2022